105 related articles for article (PubMed ID: 9373173)
21. Ultrastructural localization of a platelet-derived growth factor/v-sis-related protein(s) in cytoplasm and nucleus of simian sarcoma virus-transformed cells.
Yeh HJ; Pierce GF; Deuel TF
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2317-21. PubMed ID: 3031678
[TBL] [Abstract][Full Text] [Related]
22. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
Moscatelli D; Quarto N
J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
[TBL] [Abstract][Full Text] [Related]
23. The phenotypic characteristics of simian sarcoma virus-transformed human fibroblasts suggest that the v-sis gene product acts solely as a PDGF receptor agonist in cell transformation.
Johnsson A; Betsholtz C; Heldin CH; Westermark B
EMBO J; 1986 Jul; 5(7):1535-41. PubMed ID: 3017700
[TBL] [Abstract][Full Text] [Related]
24. Transformation by v-sis occurs by an internal autoactivation mechanism.
Bejcek BE; Li DY; Deuel TF
Science; 1989 Sep; 245(4925):1496-9. PubMed ID: 2551043
[TBL] [Abstract][Full Text] [Related]
25. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
26. v-sis oncogene-induced transformation of human fibroblasts into cells capable of forming benign tumors.
Yang D; Kohler SK; Maher VM; McCormick JJ
Carcinogenesis; 1994 Oct; 15(10):2167-75. PubMed ID: 7955050
[TBL] [Abstract][Full Text] [Related]
27. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
28. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
29. Role of phosphoinositide 3OH-kinase in autocrine transformation by PDGF-BB.
Rosenmüller T; Rydh K; Nånberg E
J Cell Physiol; 2001 Sep; 188(3):369-82. PubMed ID: 11473364
[TBL] [Abstract][Full Text] [Related]
30. A novel tetracyclic peptide, trapoxin, induces phenotypic change from transformed to normal in sis-oncogene-transformed NIH3T3 cells.
Yoshida H; Sugita K
Jpn J Cancer Res; 1992 Apr; 83(4):324-8. PubMed ID: 1506265
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
Powis G; Seewald MJ; Melder D; Hoke M; Gratas C; Christensen TA; Chapman DE
Cancer Chemother Pharmacol; 1992; 31(3):223-8. PubMed ID: 1464160
[TBL] [Abstract][Full Text] [Related]
32. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.
Keating MT; Williams LT
Science; 1988 Feb; 239(4842):914-6. PubMed ID: 2829358
[TBL] [Abstract][Full Text] [Related]
33. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
Carpenter PM; Mercola M; Mercola D
Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
35. Rapid, complete and reversible transformation by v-sis precedes irreversible transformation.
Mercola D; Carpenter PM; Grover-Bardwick A; Mercola M
Oncogene; 1992 Sep; 7(9):1793-803. PubMed ID: 1501889
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
37. Suramin binds to platelet-derived growth factor and inhibits its biological activity.
Hosang M
J Cell Biochem; 1985; 29(3):265-73. PubMed ID: 4077932
[TBL] [Abstract][Full Text] [Related]
38. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
39. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.
Betsholtz C; Johnsson A; Heldin CH; Westermark B
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6440-4. PubMed ID: 3018732
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor in human malignancy.
Silver BJ
Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
